查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1478005

多重检测免疫分析市场：依产品类型、最终用户、地区 - 全球产业分析、规模、占有率、成长、趋势、预测，2024-2031 年

Multiplex Detection Immunoassay Market by Product Type, End-Users, and Geography (North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa): Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2031
出版日期: | 出版商: Persistence Market Research | 英文 228 Pages | 商品交期: 2-5个工作天内

价格
简介目录

本研究报告是 Persistence Market Research 的市场研究报告，对全球多重检测免疫分析市场进行了详细的分析和预测。 这份综合报告提供了关键市场动态、市场成长驱动因素、课题和新兴趋势的宝贵见解。 它详细概述了医疗保健和生命科学行业的多重检测免疫分析领域，提供了独家数据和统计数据来预测 2024 年至 2031 年的市场成长轨迹。

关键见解

  • 多重检测免疫分析市场规模（2024 年）：30.35 亿美元
  • 预测市场价值（2031 年）65.02 亿美元
  • 全球市场成长率（复合年增长率，2024-2031 年）：4.2%

多重检测免疫分析市场 - 报告范围：

多重检测免疫分析市场涵盖临床诊断、药物发现和生物标记研究中使用的各种产品、技术和应用。 该市场为临床实验室、製药公司、生物技术公司和学术研究机构提供多重检测免疫分析平台和分析方法，用于同时检测和定量单一样本中的多种分析物。 多重检测免疫分析能够对生物标记、细胞激素、蛋白质和抗体进行高通量分析，有助于全面分析疾病状态、药物反应和免疫功能。 市场成长是由对个人化医疗、精准诊断和生物标记驱动疗法的需求不断增长，以及免疫分析技术和分析设计的进步所推动的。

推动市场成长的因素：

全球多重检测免疫分析市场正受益于几个关键的市场成长驱动因素。 慢性病、传染病和癌症的流行正在推动对用于早期检测、诊断和监测疾病进展的多重免疫测定解决方案的需求。 此外，检测灵敏度、特异性和多重功能的进步使研究人员能够以更高的精度和准确度分析复杂的生物样品。 此外，多重检测免疫分析平台在临床试验、伴随诊断和个人化医疗计划中的采用正在推动市场扩张。 此外，对生物标记发现、患者分层和药物基因组学研究的日益关注，为转化医学和精准肿瘤学中的多重免疫分析应用创造了机会。

市场限制因素：

儘管成长前景广阔，但多重检测免疫分析市场仍面临分析标准化、验证和监管合规性的课题。 多重检测免疫测定缺乏标准化方案和参考材料，这可能促使测定性能和结果解释的可变性，影响研究和实验室之间的再现性和可比性。 此外，对测定特异性、交叉反应性和内源性物质干扰的担忧可能会影响多重免疫测定的测量准确性和可靠性。 此外，检测验证、品质控制和临床效用评估的监管要求对市场进入和商业化提出了课题。 为了解决这些障碍，行业利益相关者、监管机构和标准机构必须共同努力，为多重免疫测定的开发和验证建立最佳实践和指南。

市场机会：

由于技术创新、市场扩张和应用多样化，多重检测免疫分析市场提供了巨大的成长机会。 单细胞分析、空间分析和多组学整合等新兴趋势为多重免疫分析技术解决复杂的生物学问题和疾病机制提供了新途径。 高通量免疫分析平台、微流体装置和即时检测系统的开发使得能够在临床和研究环境中快速且经济高效地分析生物标记。 此外，精准医学中伴随诊断、免疫监测和患者分层的需求不断增长，为多重免疫分析和平台创造了新的市场机会。 策略伙伴关係、协作以及研发投资对于跟上新兴趋势并维持动态多重检测免疫分析领域的市场领先地位至关重要。

本报告涵盖的主要问题

  • 推动多重检测免疫分析市场全球成长的因素有哪些？
  • 免疫分析技术与分析设计的进步如何改变多重检测免疫分析的竞争格局？
  • 市场参与者在多重检测免疫分析领域面临哪些主要课题与机会？
  • 哪些应用和最终用户领域对多重检测免疫分析产品和服务具有最大的成长潜力？
  • 领先公司采取哪些策略来维持市场竞争力并推动创新？

竞争资讯与业务策略：

全球多重检测免疫分析市场的领导者，包括诊断公司、生物技术公司和生命科学供应商，正在专注于技术创新、产品差异化和市场扩张，以获得竞争优势。 这些公司投资研发，开发针对特定临床和研究应用的下一代多重免疫分析平台、分析方法和试剂。 我们也与意见领袖、临床研究网络和製药公司结成策略联盟，以验证产品性能、展示临床实用性并扩大市场范围。 此外，我们对客户支援、技术培训和科学教育措施的关注提高了免疫分析技术竞争格局中的品牌声誉和客户忠诚度。

主要公司简介：

  • Bio-Rad Laboratories Inc.
  • Thermo Fisher Scientific
  • EMD Millipore (Merck KGaA.)
  • Becton, Dickinson and Company.
  • Microsynth AG
  • Quansys Biosciences Inc
  • QIAGEN N.V.
  • F. Hoffmann-La Roche Ltd.
  • Danaher Corporation.
  • Luminex Corporation

多重检测免疫分析市场研究细分：

多重侦测免疫分析市场：依技术划分

  • 基于核酸的技术
  • 基于蛋白质的技术
  • 基于生物感测器的方法

多重检测免疫分析市场：依分析类型划分

  • 平面测定
  • 混合蛋白晶片（多重 ELISA）
  • 抗体阵列
  • 基于微珠的检测
  • 磁珠底座
  • 非磁珠底座

多重侦测免疫分析市场：依应用划分

  • 疾病检测
  • 传染病检测
  • 自体免疫疾病检测
  • 其他疾病测试
  • 食品污染检验
  • 研究与开发
  • 兽医疾病检查

多重检测免疫分析市场：依最终用户划分

  • 製药公司
  • 临床研究所
  • 食品和饮料公司
  • 学术研究所
  • 诊断中心
  • 生技中心

多重检测免疫分析市场：依地区

  • 北美
  • 拉丁美洲
  • 欧洲
  • 亚太地区
  • 中东和非洲 (MEA)

目录

第 1 章执行摘要

第二章市场概述

  • 市场范围/分类
  • 市场定义

第三章市场动态

  • 宏观经济因素
  • 促进因素
    • 供应方驱动因素
    • 需求方驱动因素
  • 抑制因素
  • 机会
  • 趋势

第四章市场状况

  • 监管场景
  • PEST分析
  • 科技的演变

第五章全球多重检测免疫分析市场价值分析

  • 过去的市场价值分析，2019-2023 年
  • 当前与未来市场价值预测：2022-2024 年
    • 年成长趋势分析
    • 绝对数量机会分析

第 6 章全球多重检测免疫分析市场分析：依分析类型

  • 简介/主要发现
  • 历史市场规模分析：依检测类型，2019-2023 年
  • 2022-2024 年当前及未来市场规模分析及预测（依检测类型）
    • 平面测定
    • 基于微珠的检测
  • 市场吸引力分析：依检测类型

第 7 章全球多重检测免疫分析市场分析：依技术

  • 简介/主要发现
  • 过去的市场规模分析：依技术分类，2019-2023 年
  • 当前和未来的市场规模分析和预测：依技术分类，2022-2024 年
    • 基于核酸的技术
    • 基于蛋白质的技术
    • 基于生物感测器的技术
  • 市场吸引力分析：依技术分类

第 8 章全球多重检测免疫分析市场分析：依应用

  • 简介/主要发现
  • 过去的市场规模分析：依应用划分，2019-2023 年
  • 当前和未来的市场规模分析和预测：依应用划分，2022-2024 年
    • 疾病检测
    • 食品污染检验
    • 研究与开发
    • 兽医疾病检查
  • 市场吸引力分析：依应用分类

第 9 章全球多重侦测免疫分析市场分析：依最终使用者划分

  • 简介/主要发现
  • 过去的市场规模分析：依最终用户划分，2019-2023 年
  • 当前和未来的市场规模分析和预测：依最终用户划分，2022-2024 年
    • 製药公司
    • 临床研究所
    • 食品和饮料公司
    • 学术研究所
    • 诊断中心
    • 生技中心
  • 市场吸引力分析：依最终用户分类

第 10 章依地区划分的全球多重检测免疫分析市场分析

  • 简介
  • 过去的市场规模分析：依地区划分，2019-2023 年
  • 当前市场规模分析与预测：依地区划分，2022-2024 年
    • 北美
    • 拉丁美洲
    • 欧洲
    • 南亚
    • 东亚
    • 大洋洲
    • 中东/非洲
  • 市场吸引力分析：依地区划分

第十一章北美多重检测免疫分析市场分析

第十二章拉丁美洲多重检测免疫分析市场分析

第13章欧洲多重检测免疫分析法定市场分析

第十四章南亚多重检测免疫分析市场分析

第十五章东亚多重检测免疫分析市场分析

第十六章大洋洲多重检测免疫分析市场分析

第十七章中东与非洲多重检测免疫分析市场分析

第十八章新兴国家多重检测免疫分析市场分析

  • 简介
    • 市值比分析：依主要国家分类
    • 世界与各国成长比较
  • 法国多重检测免疫分析市场分析
    • 简介
    • 市场价值分析与预测：依市场分类
      • 依检测类型
      • 依技术
      • 依用途
      • 依最终用户
  • 西班牙多重检测免疫分析市场分析
    • 简介
    • 市场价值分析与预测：依市场分类
      • 依检测类型
      • 依技术
      • 依用途
      • 依最终用户
    • 西班牙多重检测免疫分析市场 - 竞争格局
  • 日本多重检测免疫分析市场分析
    • 简介
    • 市场价值分析与预测：依市场分类
      • 依检测类型
      • 依技术
      • 依用途
      • 依最终用户

第19章竞争分析

  • 公司股票分析
  • 竞争对手仪表板
  • 衝突详情
    • Bio-Rad Laboratories Inc.
    • Thermo Fisher Scientific
    • EMD Millipore（Merck KGaA.）
    • Becton, Dickinson and Company.
    • Microsynth AG
    • Quansys Biosciences Inc
    • QIAGEN NV
    • F. Hoffmann-La Roche Ltd.
    • Danaher Corporation.
    • Luminex Corporation

第 20 章先决条件与使用的缩写

第21章研究方法

简介目录
Product Code: PMRREP11542

Persistence Market Research, a leading market research firm, has conducted an in-depth analysis of the global Multiplex Detection Immunoassay Market. This comprehensive report provides valuable insights into key market dynamics, growth drivers, challenges, and emerging trends. It offers a detailed overview of the multiplex detection immunoassay segment within the healthcare and life sciences industry, presenting exclusive data and statistics projecting the market's growth trajectory from 2024 to 2031.

Key Insights:

  • Multiplex Detection Immunoassay Market Size (2024): USD3.035 Bn
  • Projected Market Value (2031): USD6.502 Bn
  • Global Market Growth Rate (CAGR 2024 to 2031): 4.2%

Multiplex Detection Immunoassay Market - Report Scope:

The Multiplex Detection Immunoassay Market encompasses a wide range of products, technologies, and applications used in clinical diagnostics, drug discovery, and biomarker research. This market serves clinical laboratories, pharmaceutical companies, biotechnology firms, and academic research institutions, offering multiplex immunoassay platforms and assays for simultaneous detection and quantification of multiple analytes in a single sample. Multiplex immunoassays enable high-throughput analysis of biomarkers, cytokines, proteins, and antibodies, facilitating comprehensive profiling of disease states, drug responses, and immune function. Market growth is driven by increasing demand for personalized medicine, precision diagnostics, and biomarker-driven therapeutics, as well as advancements in immunoassay technology and assay design.

Market Growth Drivers:

The global Multiplex Detection Immunoassay Market benefits from several key growth drivers. The growing prevalence of chronic diseases, infectious diseases, and cancer fuels demand for multiplex immunoassay solutions for early detection, diagnosis, and monitoring of disease progression. Moreover, advancements in assay sensitivity, specificity, and multiplexing capabilities enable researchers to analyze complex biological samples with greater precision and accuracy. Furthermore, the adoption of multiplex immunoassay platforms in clinical trials, companion diagnostics, and personalized medicine initiatives drives market expansion. Additionally, the increasing focus on biomarker discovery, patient stratification, and pharmacogenomics research creates opportunities for multiplex immunoassay applications in translational medicine and precision oncology.

Market Restraints:

Despite its promising growth prospects, the Multiplex Detection Immunoassay Market faces challenges related to assay standardization, validation, and regulatory compliance. The lack of standardized protocols and reference materials for multiplex immunoassays may lead to variability in assay performance and results interpretation, affecting reproducibility and comparability across studies and laboratories. Moreover, concerns about assay specificity, cross-reactivity, and interference from endogenous substances may impact the accuracy and reliability of multiplex immunoassay measurements. Additionally, regulatory requirements for assay validation, quality control, and clinical utility assessment pose challenges for market entry and product commercialization. Addressing these barriers requires collaboration between industry stakeholders, regulatory agencies, and standards organizations to establish best practices and guidelines for multiplex immunoassay development and validation.

Market Opportunities:

The Multiplex Detection Immunoassay Market presents significant growth opportunities driven by technological innovations, market expansion, and application diversification. Emerging trends such as single-cell analysis, spatial profiling, and multi-omics integration offer new avenues for multiplex immunoassay technologies to address complex biological questions and disease mechanisms. The development of high-throughput immunoassay platforms, microfluidic devices, and point-of-care testing systems enables rapid and cost-effective analysis of biomarkers in clinical and research settings. Furthermore, the growing demand for companion diagnostics, immune monitoring, and patient stratification in precision medicine creates new market opportunities for multiplex immunoassay assays and platforms. Strategic partnerships, collaborations, and investments in research and development are essential to capitalize on emerging trends and sustain market leadership in the dynamic field of multiplex immunoassays.

Key Questions Answered in the Report:

  • What factors are driving the growth of the Multiplex Detection Immunoassay Market globally?
  • How are advancements in immunoassay technology and assay design reshaping the competitive landscape of multiplex immunoassays?
  • What are the key challenges and opportunities facing market participants in the multiplex immunoassay segment?
  • Which applications and end-user segments offer the highest growth potential for multiplex immunoassay products and services?
  • What strategies are leading companies employing to maintain their competitive edge and drive innovation in the market?

Competitive Intelligence and Business Strategy:

Leading players in the global Multiplex Detection Immunoassay Market, including diagnostic companies, biotechnology firms, and life sciences suppliers, focus on innovation, product differentiation, and market expansion to gain a competitive edge. These companies invest in research and development to develop next-generation multiplex immunoassay platforms, assays, and reagents tailored to specific clinical and research applications. Moreover, strategic collaborations with key opinion leaders, clinical research networks, and pharmaceutical partners enable companies to validate product performance, demonstrate clinical utility, and expand market reach. Furthermore, emphasis on customer support, technical training, and scientific education initiatives enhances brand reputation and customer loyalty in the competitive landscape of immunoassay technologies.

Key Companies Profiled:

  • Bio-Rad Laboratories Inc.
  • Thermo Fisher Scientific
  • EMD Millipore (Merck KGaA.)
  • Becton, Dickinson and Company.
  • Microsynth AG
  • Quansys Biosciences Inc
  • QIAGEN N.V.
  • F. Hoffmann-La Roche Ltd.
  • Danaher Corporation.
  • Luminex Corporation

Multiplex Detection Immunoassay Market Research Segmentation:

Multiplex Detection Immunoassay Market By Technique

  • Nucleic Acid Based Technique
  • Protein Based Technique
  • Biosensor Based Technique

Multiplex Detection Immunoassay Market By Assay Type

  • Planar Assay
  • Blends Protein Arrays (Multiplexed ELISA)
  • Antibody Arrays
  • Bead-based Assay
  • Magnetic Bead-based
  • Non-magnetic Bead-based

Multiplex Detection Immunoassay Market By Application

  • Disease Testing
  • Infectious Disease Testing
  • Autoimmune Disease Testing
  • Other Diseases Testing
  • Food Contamination Testing
  • Research and Development
  • Veterinary Disease Testing

Multiplex Detection Immunoassay Market By End User

  • Pharmaceutical Companies
  • Clinical Research Organizations
  • Food & Beverages Companies
  • Academic Research Institutes
  • Diagnostic Centers
  • Biotechnology Centers

Multiplex Detection Immunoassay Market By Region

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East & Africa (MEA)

Table of Contents

1. Executive Summary

  • 1.1. Global Market Outlook
  • 1.2. Analysis and Recommendations

2. Market Overview

  • 2.1. Market Coverage / Taxonomy
  • 2.2. Market Definition

3. Market Dynamics

  • 3.1. Macro-Economic Factors
  • 3.2. Drivers
    • 3.2.1. Supply Side Drivers
    • 3.2.2. Demand Side Drivers
  • 3.3. Restraints
  • 3.4. Opportunities
  • 3.5. Trends

4. Market Context

  • 4.1. Regulatory Scenario
  • 4.2. PEST Analysis
  • 4.3. Technology Evolution

5. Global Multiplex Detection Immunoassay Market Value Analysis 2019-2023 and Forecast, 2022-2024

  • 5.1. Historical Market Value (US$ Mn) Analysis, 2019-2023
  • 5.2. Current and Future Market Value (US$ Mn) Projections, 2022-2024
    • 5.2.1. Y-o-Y Growth Trend Analysis
    • 5.2.2. Absolute $ Opportunity Analysis

6. Global Multiplex Detection Immunoassay Market Analysis 2019-2023 and Forecast 2022-2024, by Assay Type

  • 6.1. Introduction / Key Findings
  • 6.2. Historical Market Size (US$ Mn) Analysis By Assay Type, 2019-2023
  • 6.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Assay Type, 2022 - 2024
    • 6.3.1. Planar Assay
      • 6.3.1.1. Blends Protein Arrays (Multiplexed ELISA)
      • 6.3.1.2. Antibody Arrays
    • 6.3.2. Bead-based Assay
      • 6.3.2.1. Magnetic Bead-based
      • 6.3.2.2. Non-magnetic Bead-based
  • 6.4. Market Attractiveness Analysis By Assay Type

7. Global Multiplex Detection Immunoassay Market Analysis 2019-2023 and Forecast 2022-2024, by Technique

  • 7.1. Introduction / Key Findings
  • 7.2. Historical Market Size (US$ Mn) Analysis By Technique, 2019-2023
  • 7.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Technique, 2022 - 2024
    • 7.3.1. Nucleic Acid Based Technique
    • 7.3.2. Protein Based Technique
    • 7.3.3. Biosensor Based Technique
  • 7.4. Market Attractiveness Analysis By Technique

8. Global Multiplex Detection Immunoassay Market Analysis 2019-2023 and Forecast 2022-2024, by Application

  • 8.1. Introduction / Key Findings
  • 8.2. Historical Market Size (US$ Mn) Analysis By Application, 2019-2023
  • 8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Application, 2022 - 2024
    • 8.3.1. Disease Testing
      • 8.3.1.1. Infectious Disease Testing
      • 8.3.1.2. Autoimmune Disease Testing
      • 8.3.1.3. Other Diseases Testing
    • 8.3.2. Food Contamination Testing
    • 8.3.3. Research and Development
    • 8.3.4. Veterinary Disease Testing
  • 8.4. Market Attractiveness Analysis By Application

9. Global Multiplex Detection Immunoassay Market Analysis 2019-2023 and Forecast 2022-2024, by End User

  • 9.1. Introduction / Key Findings
  • 9.2. Historical Market Size (US$ Mn) Analysis By End User, 2019-2023
  • 9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End User, 2022 - 2024
    • 9.3.1. Pharmaceutical Companies
    • 9.3.2. Clinical Research Organizations
    • 9.3.3. Food & Beverages Companies
    • 9.3.4. Academic Research Institutes
    • 9.3.5. Diagnostic Centers
    • 9.3.6. Biotechnology Centers
  • 9.4. Market Attractiveness Analysis By End User

10. Global Multiplex Detection Immunoassay Market Analysis 2019-2023 and Forecast 2022-2024, by Region

  • 10.1. Introduction
  • 10.2. Historical Market Size (US$ Mn) Analysis By Region, 2019-2023
  • 10.3. Current Market Size (US$ Mn) Analysis and Forecast By Region, 2022 - 2024
    • 10.3.1. North America
    • 10.3.2. Latin America
    • 10.3.3. Europe
    • 10.3.4. South Asia
    • 10.3.5. East Asia
    • 10.3.6. Oceania
    • 10.3.7. Middle East & Africa
  • 10.4. Market Attractiveness Analysis By Region

11. North America Multiplex Detection Immunoassay Market Analysis 2019-2023 and Forecast 2022-2024

  • 11.1. Introduction
  • 11.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
  • 11.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022-2024
    • 11.3.1. By Country
      • 11.3.1.1. U.S.
      • 11.3.1.2. Canada
    • 11.3.2. By Assay Type
    • 11.3.3. By Technique
    • 11.3.4. By Application
    • 11.3.5. By End User
  • 11.4. Market Attractiveness Analysis

12. Latin America Multiplex Detection Immunoassay Market Analysis 2019-2023 and Forecast 2022-2024

  • 12.1. Introduction
  • 12.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
  • 12.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022-2024
    • 12.3.1. By Country
      • 12.3.1.1. Brazil
      • 12.3.1.2. Mexico
      • 12.3.1.3. Rest of Latin America
    • 12.3.2. By Assay Type
    • 12.3.3. By Technique
    • 12.3.4. By Application
    • 12.3.5. By End User
  • 12.4. Market Attractiveness Analysis

13. Europe Multiplex Detection Immunoassay Market Analysis 2019-2023 and Forecast 2022-2024

  • 13.1. Introduction
  • 13.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
  • 13.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022-2024
    • 13.3.1. By Country
      • 13.3.1.1. U.K
      • 13.3.1.2. Germany
      • 13.3.1.3. Italy
      • 13.3.1.4. Russia
      • 13.3.1.5. France
      • 13.3.1.6. Spain
      • 13.3.1.7. Rest of Europe
    • 13.3.2. By Assay Type
    • 13.3.3. By Technique
    • 13.3.4. By Application
    • 13.3.5. By End User
  • 13.4. Market Attractiveness Analysis

14. South Asia Multiplex Detection Immunoassay Market Analysis 2019-2023 and Forecast 2022-2024

  • 14.1. Introduction
  • 14.2. Pricing Analysis
  • 14.3. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
  • 14.4. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022 - 2024
    • 14.4.1. By Country
      • 14.4.1.1. India
      • 14.4.1.2. Thailand
      • 14.4.1.3. Indonesia
      • 14.4.1.4. Malaysia
      • 14.4.1.5. Rest of South Asia
    • 14.4.2. By Assay Type
    • 14.4.3. By Technique
    • 14.4.4. By Application
    • 14.4.5. By End User
  • 14.5. Market Attractiveness Analysis

15. East Asia Multiplex Detection Immunoassay Market Analysis 2019-2023 and Forecast 2022-2024

  • 15.1. Introduction
  • 15.2. Pricing Analysis
  • 15.3. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
  • 15.4. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022 - 2024
    • 15.4.1. By Country
      • 15.4.1.1. China
      • 15.4.1.2. Japan
      • 15.4.1.3. South Korea
    • 15.4.2. By Assay Type
    • 15.4.3. By Technique
    • 15.4.4. By Application
    • 15.4.5. By End User
  • 15.5. Market Attractiveness Analysis

16. Oceania Multiplex Detection Immunoassay Market Analysis 2019-2023 and Forecast 2022-2024

  • 16.1. Introduction
  • 16.2. Pricing Analysis
  • 16.3. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
  • 16.4. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022 - 2024
    • 16.4.1. By Country
      • 16.4.1.1. Australia
      • 16.4.1.2. New Zealand
    • 16.4.2. By Assay Type
    • 16.4.3. By Technique
    • 16.4.4. By Application
    • 16.4.5. End User
  • 16.5. Market Attractiveness Analysis

17. Middle East and Africa Multiplex Detection Immunoassay Market Analysis 2019-2023 and Forecast 2022-2024

  • 17.1. Introduction
  • 17.2. Pricing Analysis
  • 17.3. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
  • 17.4. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022 - 2024
    • 17.4.1. By Country
      • 17.4.1.1. GCC Countries
      • 17.4.1.2. Turkey
      • 17.4.1.3. Northern Africa
      • 17.4.1.4. South Africa
      • 17.4.1.5. Rest of Middle East and Africa
    • 17.4.2. By Assay Type
    • 17.4.3. By Technique
    • 17.4.4. By Application
    • 17.4.5. By End User
  • 17.5. Market Attractiveness Analysis

18. Emerging Countries Multiplex Detection Immunoassay Market Analysis 2019-2023 and Forecast 2022-2024

  • 18.1. Introduction
    • 18.1.1. Market Value Proportion Analysis, By Key Countries
    • 18.1.2. Global Vs. Country Growth Comparison
  • 18.2. France Multiplex Detection Immunoassay Market Analysis
    • 18.2.1. Introduction
    • 18.2.2. Market Value (US$ Mn) Analysis and Forecast by Market Taxonomy
      • 18.2.2.1. By Assay Type
      • 18.2.2.2. By Technique
      • 18.2.2.3. By Application
      • 18.2.2.4. By End User
  • 18.3. Spain Multiplex Detection Immunoassay Market Analysis
    • 18.3.1. Introduction
    • 18.3.2. Market Value (US$ Mn) Analysis and Forecast by Market Taxonomy
      • 18.3.2.1. By Assay Type
      • 18.3.2.2. By Technique
      • 18.3.2.3. By Application
      • 18.3.2.4. By End User
    • 18.3.3. Spain Multiplex Detection Immunoassay Market - Competition Landscape
  • 18.4. Japan Multiplex Detection Immunoassay Market Analysis
    • 18.4.1. Introduction
    • 18.4.2. Market Value (US$ Mn) Analysis and Forecast by Market Taxonomy
      • 18.4.2.1. By Assay Type
      • 18.4.2.2. By Technique
      • 18.4.2.3. By Application
      • 18.4.2.4. By End User

19. Competition Analysis

  • 19.1. Company Share Analysis
  • 19.2. Competition Dashboard
  • 19.3. Competition Deep Dive
    • 19.3.1. Bio-Rad Laboratories Inc.
      • 19.3.1.1. Company Overview
      • 19.3.1.2. Product Offerings
      • 19.3.1.3. Financial Analysis
      • 19.3.1.4. Key Developments
      • 19.3.1.5. Strategy Overview
    • 19.3.2. Thermo Fisher Scientific
      • 19.3.2.1. Company Overview
      • 19.3.2.2. Product Offerings
      • 19.3.2.3. Financial Analysis
      • 19.3.2.4. Key Developments
      • 19.3.2.5. Strategy Overview
    • 19.3.3. EMD Millipore (Merck KGaA.)
      • 19.3.3.1. Company Overview
      • 19.3.3.2. Product Offerings
      • 19.3.3.3. Financial Analysis
      • 19.3.3.4. Key Developments
      • 19.3.3.5. Strategy Overview
    • 19.3.4. Becton, Dickinson and Company.
      • 19.3.4.1. Company Overview
      • 19.3.4.2. Product Offerings
      • 19.3.4.3. Financial Analysis
      • 19.3.4.4. Key Developments
      • 19.3.4.5. Strategy Overview
    • 19.3.5. Microsynth AG
      • 19.3.5.1. Company Overview
      • 19.3.5.2. Product Offerings
      • 19.3.5.3. Financial Analysis
      • 19.3.5.4. Key Developments
      • 19.3.5.5. Strategy Overview
    • 19.3.6. Quansys Biosciences Inc
      • 19.3.6.1. Company Overview
      • 19.3.6.2. Product Offerings
      • 19.3.6.3. Financial Analysis
      • 19.3.6.4. Key Developments
      • 19.3.6.5. Strategy Overview
    • 19.3.7. QIAGEN N.V.
      • 19.3.7.1. Company Overview
      • 19.3.7.2. Product Offerings
      • 19.3.7.3. Financial Analysis
      • 19.3.7.4. Key Developments
      • 19.3.7.5. Strategy Overview
    • 19.3.8. F. Hoffmann-La Roche Ltd.
      • 19.3.8.1. Company Overview
      • 19.3.8.2. Product Offerings
      • 19.3.8.3. Financial Analysis
      • 19.3.8.4. Key Developments
      • 19.3.8.5. Strategy Overview
    • 19.3.9. Danaher Corporation.
      • 19.3.9.1. Company Overview
      • 19.3.9.2. Product Offerings
      • 19.3.9.3. Financial Analysis
      • 19.3.9.4. Key Developments
      • 19.3.9.5. Strategy Overview
    • 19.3.10. Luminex Corporation
      • 19.3.10.1. Company Overview
      • 19.3.10.2. Product Offerings
      • 19.3.10.3. Financial Analysis
      • 19.3.10.4. Key Developments
      • 19.3.10.5. Strategy Overview

20. Assumptions and Acronyms Used

21. Research Methodology